Piper Sandler analyst Jason Bednar lowered the firm’s price target on Dentsply Sirona to $29 from $38 and keeps a Neutral rating on the shares after the company reported Q3 results that included revenue consistent with preliminary details and management updated organic growth and EPS guidance. The updated guidance "implies a tough" Q4 as new management works to address internal issues while the external environment is "presenting plenty of persistent" headwinds, said Bednar, who anticipates the company’s turnaround "could prove long and costly."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on XRAY:
- Dentsply Sirona Reports Third Quarter 2022 Results
- Dentsply Sirona to Participate in Upcoming Investor Conferences
- Dentsply Sirona to Host Third Quarter Conference Call on November 14th
- Dentsply Sirona Completes Internal Investigation
- Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer